Emactuzumab, a humanized immunoglobulin G1 monoclonal antibody, targets the CSF-1 receptor and inhibits macrophages in tumor tissue.

After reviewing all the data and considering input from regulators, Pfizer decided to discontinue the danuglipron program.

The Food and Drug Administration (FDA) has approved a tablet formulation of Livmarli ® (maralixibat).

Both the FDA and Novo Nordisk are advising patients and providers to check their supplies of Ozempic for counterfeit product. Individuals in possession of a counterfeit product are urged to call Novo ...

Substantially elevated GAS incidence rates seen in people experiencing homelessness, people who inject drugs, long-term care facility residents ...

The CDC has long urged vaccination for international travelers, but the recommendation for domestic travelers is a response to the ongoing outbreaks across the US.

Major health groups, including Autism Speaks, agree that childhood vaccines do not cause autism. Autism is a developmental condition that can cause problems with language, learning and social skills.

Atezolizumab, hyaluronidase-tqjs 1875mg/30000 Units; per vial; soln for SC inj; preservative-free. Atezolizumab binds to PD-L1 and blocks its interactions with both PD-1 and B7.1 receptors.

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

Authors say these factors can inform steps individuals can take to lower their risks for age-related brain diseases.

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction.